Glucocortiocoid-selective antinflammatory agents
US6506766B1 · kind B1 · utility
34Cited by
9References
35Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 5, 2000 |
| Grant date | Jan 14, 2003 |
| Priority date | — |
| Expiry date | Jul 5, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having Formula I are useful for partially or fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula I and methods of inhibiting immune or autoimmune diseases in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.